Mead Johnson Nutrition Co. (NYSE:MJN) hit a new 52-week high on Friday . The company traded as high as $92.02 and last traded at $91.58, with a volume of 524,770 shares. The stock had previously closed at $91.24.

A number of equities research analysts recently commented on the company. Susquehanna reiterated a “hold” rating on shares of Mead Johnson Nutrition in a research report on Sunday, July 17th. Goldman Sachs Group Inc. reiterated a “neutral” rating and issued a $96.00 target price (up previously from $91.00) on shares of Mead Johnson Nutrition in a research report on Friday, July 15th. Bank of America Corp. upgraded Mead Johnson Nutrition from an “underperform” rating to a “neutral” rating and set a $93.00 target price on the stock in a research report on Wednesday, July 13th. Zacks Investment Research upgraded Mead Johnson Nutrition from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research report on Tuesday, May 3rd. Finally, Credit Suisse Group AG reiterated a “buy” rating and issued a $96.00 target price on shares of Mead Johnson Nutrition in a research report on Thursday, June 30th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. Mead Johnson Nutrition has an average rating of “Hold” and a consensus price target of $89.44.

The firm has a 50-day moving average of $87.44 and a 200 day moving average of $80.73. The firm has a market capitalization of $17.14 billion and a price-to-earnings ratio of 34.64.

Mead Johnson Nutrition (NYSE:MJN) last issued its earnings results on Thursday, April 28th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.02. The business had revenue of $962.10 million for the quarter, compared to analyst estimates of $957.03 million. During the same period last year, the business posted $1.09 EPS. Mead Johnson Nutrition’s revenue was down 12.1% on a year-over-year basis. On average, analysts anticipate that Mead Johnson Nutrition Co. will post $3.51 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 5th. Stockholders of record on Monday, June 20th were given a dividend of $0.4125 per share. This represents a $1.65 annualized dividend and a dividend yield of 1.81%. The ex-dividend date was Thursday, June 16th.

In other news, SVP Christoper Richard Stratton sold 33,730 shares of the firm’s stock in a transaction dated Monday, May 2nd. The stock was sold at an average price of $86.66, for a total transaction of $2,923,041.80. Following the sale, the senior vice president now owns 5,696 shares of the company’s stock, valued at approximately $493,615.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Other hedge funds and institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Mead Johnson Nutrition by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 11,612,306 shares of the company’s stock worth $916,791,000 after buying an additional 82,099 shares in the last quarter. Thornburg Investment Management Inc. increased its position in Mead Johnson Nutrition by 155.4% in the fourth quarter. Thornburg Investment Management Inc. now owns 990,873 shares of the company’s stock worth $78,229,000 after buying an additional 602,937 shares in the last quarter. Wells Fargo & Company MN increased its position in Mead Johnson Nutrition by 0.6% in the fourth quarter. Wells Fargo & Company MN now owns 778,492 shares of the company’s stock worth $61,462,000 after buying an additional 4,269 shares in the last quarter. Victory Capital Management Inc. increased its position in Mead Johnson Nutrition by 3,822.6% in the fourth quarter. Victory Capital Management Inc. now owns 453,808 shares of the company’s stock worth $35,828,000 after buying an additional 442,239 shares in the last quarter. Finally, Mizuho Trust & Banking Co. Ltd. increased its position in Mead Johnson Nutrition by 3.4% in the fourth quarter. Mizuho Trust & Banking Co. Ltd. now owns 353,068 shares of the company’s stock worth $28,009,000 after buying an additional 11,640 shares in the last quarter.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.